← Back to Search

Behavioral Intervention for Impulsivity Related to Alcohol Consumption

N/A
Recruiting
Led By Uraina Clark, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial looks at how stress affects behavior and the brain, to understand how social, behavioral, and neural factors influence alcohol consumption.

Who is the study for?
This trial is for right-handed, English-speaking African Americans aged between 21 and 35 who are interested in understanding how stress affects impulsivity and alcohol use. It's not suitable for those under 21 or left-handed individuals.Check my eligibility
What is being tested?
The study tests a task-based behavioral intervention to see how it impacts impulsivity when facing stereotype threats, using fMRI to track brain activity and its relation to alcohol consumption.See study design
What are the potential side effects?
Since this is a non-medical intervention involving tasks and fMRI scans, side effects may include discomfort from the scanning environment or stress from the tasks but no direct medical side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood oxygen-level dependent (BOLD) signal
Resting-state functional connectivity in brain regions

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: stress exposureActive Control1 Intervention
exposure to stress threat
Group II: no stress exposurePlacebo Group1 Intervention
no threat stress

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
862 Previous Clinical Trials
525,346 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
802 Previous Clinical Trials
1,365,165 Total Patients Enrolled
Uraina Clark, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Media Library

stress exposure Clinical Trial Eligibility Overview. Trial Name: NCT05675332 — N/A
Alcohol Consumption Research Study Groups: no stress exposure, stress exposure
Alcohol Consumption Clinical Trial 2023: stress exposure Highlights & Side Effects. Trial Name: NCT05675332 — N/A
stress exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675332 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this medical research?

"This experiment will include up to 280 individuals between 21 and 35 years old who struggle with alcohol addiction. Essential criteria for application are fluency in English, age restriction (21-35), and right handedness."

Answered by AI

Is the age range of participants in this investigation restricted to those under 40?

"According to the stipulations of this clinical trial, individuals between 21 and 35 years old are admissible. Additionally, there are 22 trials tailored for minors aged 18 or below as well as 165 studies catering to senior citizens over 65+."

Answered by AI

Is enrollment for this clinical investigation still accessible to individuals?

"Based on the data provided by clinicaltrials.gov, this trial has stopped accepting participants at this time; however, a quick search reveals that 256 other trials are actively recruiting patients. Initially posted in December 9th 2022 and most recently updated on December 22nd of the same year, there presently no openings for this study."

Answered by AI
~159 spots leftby Jan 2026